Novavax
NVAX
#5394
Rank
A$2.14 B
Marketcap
A$13.03
Share price
-0.11%
Change (1 day)
20.10%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): A$0.75 Billion

According to Novavax's latest financial reports the company's current earnings are A$1.08 Billion. , an increase over its 2024 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 A$0.65 B-396.87%
2024 -A$0.23 Billion-70.39%
2023 -A$0.75 Billion-16.59%
2022 -A$0.9 Billion-62.58%
2021 -A$2.4 Billion320.54%
2020 -A$0.58 Billion234.22%
2019 -A$0.18 Billion-30.17%
2018 -A$0.25 Billion1.69%
2017 -A$0.25 Billion-36.44%
2016 -A$0.38 Billion70.4%
2015 -A$0.23 Billion89.27%
2014 -A$0.12 Billion59.83%
2013 -A$73.37 Million81.9%
2012 -A$40.34 Million50.33%
2011 -A$26.83 Million
2009 -A$52.95 Million8.8%
2008 -A$48.67 Million18.01%
2007 -A$41.24 Million18.33%
2006 -A$34.86 Million168.31%
2005 -A$12.99 Million-62.51%
2004 -A$34.65 Million52.4%
2003 -A$22.74 Million-28.21%
2002 -A$31.67 Million
2000 -A$18.05 Million177%
1999 -A$6.52 Million-11.54%
1998 -A$7.37 Million10.64%
1997 -A$6.66 Million-9.62%
1996 -A$7.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.35 B 3,296.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$15.00 B 2,179.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.76 B 3,055.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.17 B 2,054.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$1 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$29.26 M-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.51 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.37 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA